Fisher Scientific is a comprehensive scientific supply and services company that provides a wide range of products and solutions for research, healthcare, education, and industrial applications. Here are three key paragraphs about the company:
Fisher Scientific is a global leader in supplying laboratory equipment, chemicals, consumables, and safety products across multiple scientific disciplines. Their extensive product catalog spans categories like antibodies, chemicals, life sciences, safety equipment, lab furniture, and specialized scientific instruments. With brands like Thermo Scientific, Fisherbrand, and partnerships with leading manufacturers, they offer comprehensive solutions for researchers, educators, and professionals in fields ranging from cell biology to industrial testing.
The company goes beyond just product sales by providing a robust ecosystem of services and programs designed to support scientific workflows. These include the Edge program, New Lab Start-Up support, sustainability initiatives, eProcurement integration solutions, and Unity Lab Services. They also offer tools like chemical structure search platforms, custom assay design tools, and financial solutions to help streamline research and procurement processes for their customers.
Customer convenience and comprehensive support are central to Fisher Scientific’s approach. Their online platform allows users to manage orders, create product lists, track fund usage, request quotes, and access critical documents like safety data sheets. They continuously offer promotional deals, clearance sales, and special offers across product categories, making scientific supplies more accessible. Additionally, they provide resources for various scientific applications such as cell analysis, genomics, microbiology, and quality control monitoring, positioning themselves as a one-stop solution for scientific research and industrial testing needs.
Join +20,000 subscribers receiving alerts.
Join thousands of investors who rely on StockWire X for timely, accurate market intelligence.
StockWire X delivers fast, reliable, and actionable insights into significant developments across global markets, with coverage spanning technology, biotechnology, healthcare, financials, and emerging industries. Our mission is to provide clear, data-driven content that empowers investors to identify opportunities and make informed decisions ahead of the market.
Our network spans key financial and investment hubs worldwide, ensuring subscribers receive timely updates on market-moving announcements, news, macroeconomic trends, and corporate developments.
Use of Technology
We harness advanced technologies to enhance the speed, accuracy, and relevance of our reporting.
While technology accelerates our workflow, every piece of content is selected, validated, and published by human professionals, in accordance with best practices for accuracy, transparency, and investor value. This hybrid approach ensures speed without compromising editorial integrity.
Feedback and Accuracy
We are committed to accuracy and fairness in our reporting. If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
StockWire X provides readers with access to market news, educational content, and commentary from financial services professionals, industry experts, and companies (“Contributors”).
StockWire X does not hold an Australian Financial Services Licence (AFSL) and relies on the exemption available under section 911A(2)(eb) of the Corporations Act 2001 (Cth) in respect of any financial product advice provided.
Any advice or information published by StockWire X is general in nature only and has been prepared without taking into account your personal objectives, financial situation, or needs. Before acting on any information, you should consider whether it is appropriate for your circumstances and seek independent, licensed financial advice. You should also obtain and read any relevant Product Disclosure Statement (PDS) or other offer document before making an investment decision.
StockWire X makes no guarantee as to the accuracy, completeness, or timeliness of the information provided, and accepts no responsibility for any loss arising from reliance on it. All content is published in good faith for informational purposes only.
StockWire X may have commercial relationships with some contributors or companies mentioned in our content. Any such relationships will be disclosed where relevant.
If you believe any information we have published is inaccurate, incomplete, or misleading, please contact us at admin@stockwirex.com so we can review and address the matter promptly.
